Hancock, G. R.
Young, K. S.
Hosfield, D. J.
Joiner, C.
Sullivan, E. A.
Yildiz, Y.
Lainé, M.
Greene, G. L. http://orcid.org/0000-0001-6894-8728
Fanning, S. W. http://orcid.org/0000-0002-9428-0060
Funding for this research was provided by:
Susan G. Komen (CCR19608597)
Ludwig Institute for Cancer Research
Article History
Received: 15 August 2022
Accepted: 17 November 2022
First Online: 14 December 2022
Competing interests
: The authors declare no competing Non-Financial Interests, but the following Competing Financial Interest: D.J.H., G.L.G., and S.W.F. are inventors on the composition and use patents for the isoquinoline molecules discussed in this paper. The U.S.A. patent application number is 63/151,479.